Navigation Links
AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles

ults to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the ability of AEterna Zentaris to implement its business strategies, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of AEterna Zentaris to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements.at www.aeternazentaris.com.

CONTACT: Jenene Thomas, Senior Director, Investor Relations & CorporateCommunications, (418) 655-6420, ; PaulBurroughs, Media Relations, (418) 652-8525, ext. 406, jenene.thomas@aeternazentaris.com paul.burroughs@aeternazentaris.com

Ticker Symbol: (Toronto:AEZ.),(NASDAQ-NMS:AEZS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
11. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
(Date:7/25/2014)... PORT OF SPAIN, Trinidad and Tobago , ... Drugs Division of the Trinidad & Tobago Ministry ... the market, an innovative therapy that significantly increases the ... indicated for patients infected with the genotype 1 ... under the trade brand INCIVO®. ...
(Date:7/25/2014)... -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce ... and the Letter of Intent issued on July 11, ... Agreement. Charles R. Shirley , Managing ... Mr. David Pecoraro and Buzznbrewz.com join SLNX,s ... sector and developed a tremendous network of contacts who ...
(Date:7/25/2014)... July 25, 2014 Research and Markets ... Ophthalmic Diagnostic Devices Market 2014-2018" report to their ... About Ophthalmic Diagnostic Device An ... identify a defect or deficiency in the human visual ... disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
(Date:7/25/2014)... 25, 2014 In recent years, men have ... to reverse the symptoms associated with age-related testosterone decline. Amid ... large, a new case study from Renew Man ... testosterone therapy using bioidentical hormones. , The case study ... Seattle who found himself beginning to feel the effects of ...
(Date:7/25/2014)... As reported by the Statesman Journal in the article ... police in Salem, MA as well as several other states ... epidemic that has taken many lives during the past couple ... in which police were able to make two arrests by ... to be the victim and claiming to want to buy ...
(Date:7/25/2014)... July 25, 2014 (HealthDay News) -- Seniors are more ... people, a new study finds. "Almost any type ... from the age of 25 on," study co-author Randi ... a university news release. However, Martin said, this ... on processing in older adults compared with younger adults. ...
(Date:7/25/2014)... Island (PRWEB) July 25, 2014 Reproductive ... to announce that Dr. Kerri Luzzo, Lead Physician at ... Award" for her professional accomplishments in fertility care and ... , At the 10th Annual PBN Awards ceremony held ... Island, 40 of the most highly regarded, emerging leaders ...
(Date:7/25/2014)... News) -- The human brain can preserve oxygen to ... study finds. Although dehydration significantly reduces blood ... that the brain compensates by increasing the amount of ... has helped us understand a lot more about how ... conditions," study first author Steven Trangmar, a researcher at ...
Breaking Medicine News(10 mins):Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Distractions Seem More Troublesome With Age 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Human Brain Has Coping Mechanism for Dehydration 2
... Scientists at the University of Liverpool have identified high levels ... may suggest why they live longer than other rodents and ... recently generated the first whole-genome sequencing data of the naked ... years and is resistant to cancer - to understand its ...
... , THURSDAY, Nov. 3 (HealthDay News) --,When an ... can suffer fatal injuries, a new report suggests. That,s ... associated with these natural disasters occur when bridges and roads ... is disrupted, according to a group of Boston researchers who ...
... News) -- Smokers are more likely to kick the habit ... processes emotions was damaged by the stroke, researchers say. ... smoking before they had a stroke were much more likely ... about quitting. These findings may lead to new ways ...
... , THURSDAY, Nov. 3 (HealthDay News) -- A new ... calls into question the widespread practice of classifying children ... and their IQ scores, researchers report. ... many school systems in the United States to determine ...
... PHILADELPHIA - A research group at the Perelman School ... John Lynch, MD, PhD, assistant professor of Medicine in ... Institute (NCI) grant to establish a Barrett,s esophagus translational ... Timothy Wang) and the Mayo Clinic (led by Dr. ...
... federal government is investing billions of dollars to encourage ... technology so that all Americans can benefit from the ... about potential harm are emerging as providers increasingly rely ... information technologies to deliver care. ,HEALTH IT ...
Cached Medicine News:Health News:Scientists identify genes that may signal long life in naked mole-rats 2Health News:Earthquakes Put Millions of Lives, Major Cities at Risk 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Study Finds No Link Between Dyslexia and IQ 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 3
... magnification. The true benefit of this system ... focal clarity is made possible to to ... aluminum bar and individual pupillary adjustments provides ... focal alignment, eliminating headache and eyestrain., ,Ideal ...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: